Prospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Oct 18, 2017; 9(29): 1141-1157
Published online Oct 18, 2017. doi: 10.4254/wjh.v9.i29.1141
Table 2 Comparison of Traditional Chinese Medicine study cohort with liver injury study cohort
ParameterTCM study cohortLiver injury study cohortP (difference between both cohorts)
Patients (n)2147026
ALT (U/L, mean ± SD)NA300.0 ± 172.9
Females (%)71.984.6NS
Age (yr, mean ± SD)52.7 ± 14.057.6 ± 10.5NS
Chronic diseases (%)58.966.6NS
Duration of complaints (yr, median)7.88.5NS
Duration of herbal TCM treatment (d, median, range)20 (8-77)19.5 (7-28)NS
Total dosage of herbal TCM (g, mean, range)88 ± 18 (18-208)95 ± 30 (43-155)< 0.05
Hospital stay (d, mean ± SD)26.2 ± 5.226.1 ± 4.0NS